OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...

Inovonics Inc. stepped up by releasing the Model 551, arguably the ultimate FM/HD modulation monitor. Though it has been on ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

This makes effective monitoring and early intervention crucial ... leading to a teleconsultation and subsequent referral to ...